Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lantheus Holdings Inc LNTH

Healthcare Medical Instruments & Supplies
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

Business Wire February 25, 2020

Lantheus and Progenics Agree to Amended Transaction Terms

Business Wire February 20, 2020

Lantheus Holdings to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Business Wire February 18, 2020

Lantheus Holdings to Host Fourth Quarter and Full Year 2019 Earnings Conference Call on February 25, 2020 at 8:00 a.m. Eastern Time

Business Wire February 18, 2020

Lantheus Announces Topline Results for BENEFIT 1 LVEF Clinical Trial

Business Wire February 3, 2020

Lantheus Holdings Announces Senior Leadership Appointment

Business Wire January 27, 2020

Lantheus Holdings Announces Senior Leadership Appointment

Business Wire January 13, 2020

Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference

Business Wire November 21, 2019

Lantheus Releases Comprehensive Strategic Plan for Progenics

Business Wire November 7, 2019

Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results

Business Wire October 31, 2019

Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference

Business Wire October 29, 2019

Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors

GlobeNewswire October 28, 2019

Progenics Highlights Additional Serious Concerns About Velan Capital, L.P.

GlobeNewswire October 23, 2019

Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time

Business Wire October 17, 2019

SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, PGNX, DOVA Shareholders About Its Ongoing Investigations

GlobeNewswire October 8, 2019

SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.

PR Newswire October 4, 2019

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Progenics Pharmaceuticals, Inc. to Lantheus Holdings, Inc. is Fair to Shareholders

GlobeNewswire October 3, 2019

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Progenics Pharmaceuticals, Inc.

PR Newswire October 2, 2019

Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company

Business Wire October 2, 2019

Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference

Business Wire August 22, 2019